EyePoint Pharmaceuticals, Inc. (EYPT): Price and Financial Metrics
EYPT Price/Volume Stats
| Current price | $6.21 | 52-week high | $23.97 |
| Prev. close | $6.63 | 52-week low | $5.54 |
| Day low | $6.21 | Volume | 408,900 |
| Day high | $6.63 | Avg. volume | 833,657 |
| 50-day MA | $7.15 | Dividend yield | N/A |
| 200-day MA | $8.58 | Market Cap | 426.81M |
EYPT Stock Price Chart Interactive Chart >
EyePoint Pharmaceuticals, Inc. (EYPT) Company Bio
EyePoint Pharmaceuticals (formerly pSivida Corp.) develops sustained-release drug-delivery products for treating eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior uveitis. The company was founded in 1987 and is based in Watertown, Massachusetts.
EYPT Price Returns
| 1-mo | N/A |
| 3-mo | -12.78% |
| 6-mo | -30.30% |
| 1-year | -71.90% |
| 3-year | -51.41% |
| 5-year | -32.48% |
| YTD | -16.64% |
| 2024 | -67.76% |
| 2023 | 560.29% |
| 2022 | -71.41% |
| 2021 | 86.02% |
| 2020 | -57.55% |
Continue Researching EYPT
Here are a few links from around the web to help you further your research on EyePoint Pharmaceuticals Inc's stock as an investment opportunity:EyePoint Pharmaceuticals Inc (EYPT) Stock Price | Nasdaq
EyePoint Pharmaceuticals Inc (EYPT) Stock Quote, History and News - Yahoo Finance
EyePoint Pharmaceuticals Inc (EYPT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...